Vaccination against human papilloma virus in men: situation and proposals

• Javier Cortés ^[3] ; Ángel Gil ^[4] ; Federico Martinón ^{[5] [7]} ; Francisco Xavier Bosch ^{[1] [2]} ; José Manuel Ramón y Cajal ^[6]
  1. [1] Institute Catalá Oncología

     Institute Catalá Oncología

     Barcelona, España

     
  2. [2] Universitat Oberta de Catalunya

     Universitat Oberta de Catalunya

     Barcelona, España

     
  3. [3] Royal Academy of Medicine of the Balearic Islands.
  4. [4] Rey Juan Carlos University.
  5. [5] Pediatric Service. University Clinical Hospital of Santiago de Compostela.
  6. [6] Gynecology Service. Hospital of San Jorge, Huesca
  7. [7] Group of Genetics, Vaccines, Infections and Pediatrics. Sanitary Research Institute of Santiago de Compostela.

  Mostrar afiliaciones +
• Localización: Academic Journal of Health Sciences: Medicina Balear, ISSN-e 2255-0560, Vol. 37, Nº. 3, 2022, págs. 166-170
• Idioma: inglés
• DOI: 10.3306/AJHS.2022.37.03.166
• Títulos paralelos:
  • Vacunación contra el virus del papiloma humano en hombres: situación y propuestas
• Enlaces
  • Texto completo (pdf)
• Dialnet Métricas: 1 Cita
• Resumen
  • español

    Se describe la epidemiología causal de la patología papiloma virus causal en el hombre y su incidencia y la situación de su actividad preventiva en España, no conforme con la recomendación que la evidencia científica ha formulado y que numerosos países de nuestro entorno sí están siguiendo. Se detallan líneas de acción al respecto que se consideran preferentes desde el punto de vista de acción político – sanitaria.

  • English

    The causal epidemiology of papillomavirus pathology in man and its incidence and the status of its preventive activity in Spain are described, which does not conform to the recommendation that scientific evidence has formulated and that many countries in our environment are following. Lines of action are detailed in this regard that are considered preferred from the point of view of health political action.

• Referencias bibliográficas
  • Kjaer SK, Chackerian B, van den Brule AJ, Svare EI, Paull G, Walbomers JM et al.: High-risk human papillomavirus ...
  • Available in https://www.who.int/es/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis) Access 01.08.2021.
  • Castellsagué X, Iftner T, Roura E, Vidart JA, Kjaer SK, Bosch FX et al.: Prevalence and genotype distribution of human papillomavirus infection...
  • Spanish Society of Epidemiology. Papilloma Virus and Cancer. Available in:https://www.seepidemiologia.es/documents/dummy/4monografiaVirusPapilomaYCancer.pdf....
  • Szymonowicz KA, Chen J.: Biological and clinical aspects of HPV-related cancers Cancer Biol Med. 2020; 17: 864-78.
  • Available in:https://www.aecc.es/es/todo-sobre-cancer/que-es-cancer/factores-riesgo Access 02.08.2021.
  • López, N, Torné A, Franco A, San-Martín, M, Viayna E, Barrull C et al.: Epidemiologic and economic burden of HPV diseases in Spain:...
  • Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al.: Human papillomavirus is a necessary cause of invasive cervical cancer...
  • Ghebreyesus TA, Director General.: Reunión Ejecutiva OMS Intercontinental Hotel, Genève, Confédération Suisse. 19 May 2018.
  • Cortés J, Bosch X, Concha A, González A, Martinón F, Ortiz de Lejarazu R et al.: Asociación Española contra el Cáncer: Documento...
  • Giuliano AR, Lazcano-Ponce E, Villa LL, Flores R, Salmeron J, Lee J-H et al.: The human papillomavirus infection in men study: human...
  • Ingles DJ, Lin HY, Fulp WJ, Sudenga SL, Lu B, Schabath MB et al.: An analysis of HPV infection incidence and clearance by genotype and age...
  • Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S.: Cervical human papillomavirus prevalence in 5 continents:...
  • Giuliano AR, Lee J-H, Fulp W, Villa LL, Lazcano-Ponce E, Papenfuss MR, Abrahamsen M et al.: Incidence and clearance of genital human...
  • Albero G, Villa LL, Lazcano-Ponce E, Fulp W, Papenfuss MR, Nyitray AG et al.: Male circumcision and prevalence of genital...
  • Chatuverdi AK, Engels EA, Pfeiffer RM, Hernández BY, Weihong X, Kim E et al.: Human papillomavirus and rising oropharyngeal cancer...
  • Giuliano AR, Viscidi R, Torres N, Ingles DJ, Sudenga SL, Villa LL et al.: Seroconversion Following Anal and Genital HPV Infection ...
  • Stanley M.: Program Research Epidemiology of Cancer. Cambridge Univ. Presented at EUROGIN 2018. 2-5 December. Lisbon. Portugal.
  • Cervarix® summary product characteristics. Available in https://cima.aemps.es/cima/dochtml/ft/07419004/FT_07419004.html Access...
  • Gardasil9® summary product characteristics. Available in https://cima.aemps.es/cima/dochtml/ft/1151007002/FT_1151007002.html Access...
  • Available in: https://search.usa.gov search?query=gardasil9+expanded&affiliate=fda1 Access 03.07.2021
  • Global Advisory Committee on Vaccine Safety (GACVS). Weekly Epidemiological Record: 92; 28. 14 de julio de 2017.
  • Majed L, Bresse X, El Mouaddin N, Schmidt A, Daniels VJ, Pavelyev et al.: Public health impact and cost-effectiveness of a nine-valent gender-neutral...
  • Simons JJM, Vida N, Westra TA, Postma MJ.: Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the...
  • Qendri V, Bogaards JA, Baussano I, Lazzarato F, Vänskä S, Berkhof J.: The cost-effectiveness profile of sex-neutral HPV immunisation...
  • Vänskä S, Luostarinen T, Baussano I, Apter D, Eriksson T, Natunen K et al.: Vaccination With Moderate Coverage Eradicates Oncogenic...
  • Available in https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/vacunas/profesionales/vph.htm Access 27.08.2021.
  • Available in:https://vacunasaep.org/profesionales/noticias/VPH-informe-ECDC-vacunacion-varones-y-otros-temas Access 03.08.2021.
  • European Commission. Europe’s Beating Cancer Plan. Communication from the Commission to the European Parliament ...
  • Marra F, Cloutier K, Oteng B, Marra C, Ogilvie G.: Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic...
  • Available in: https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/calendario-y-coberturas/coberturas/docs/Tabla11.pdf)...
  • K Pollock (2019). Adolescent male vaccination in the United Kingdom - a victory for equality. www.HPVWorld.com, 94.
  • Linertová R, Guirado Fuentes C, Toledo Chávarri A, Vallejo Torres L, García Pérez L, Delgado Rodríguez J et al.: Vacuna...
  • Available in https://www.euskadi.eus/informacion/vacuna-contra-el-virus-del-papiloma/web01-a2adik/es/ Access 10.09.2021
  • Available in:https://saludcantabria.es/index.php?page=vacunaciones Access 10.09.2021
  • Available in:https://salutpublica.gencat.cat/web/.content/minisite/aspcat/promocio_salut/vacunacions/00manual_de_vacunacions/capitols_i_annexos_manual/apartat_4_vacunes_disponibles/Manual-Vacunacions-apartat-4_12.pdf...
  • Available in:https://www.saludcastillayleon.es/es/vacunaciones/vacunacion-frente-virus-papiloma-humano-vph-2019 Access 11.09.2021
  • Available in https://www.who.int/news/item/22-07-2021-vaccine-inequity-undermining-global-economic-recovery Access 02.09.2021.
  • Colzani E, Johansen K, Johnson H, Celentano LP.: Human papillomavirus vaccination in the European Union/European Economic Area and...
  • Lehtinen M, Baussano I, Paavonen J, Vänska S, Dillner J.: Eradication of human papillomavirus and elimination of HPV-related...